Vitamin D-Binding Protein Clearance Ratio Is Significantly Associated with Glycemic Status and Diabetes Complications in a Predominantly Vitamin D-Deficient Population
暂无分享,去创建一个
[1] N. Abdella,et al. Cross-sectional study of the determinants and associations of sex hormone-binding globulin concentrations in first degree relatives (FDR) of patients with Type 2 Diabetes Mellitus. , 2017, Diabetes research and clinical practice.
[2] T. Dschietzig,et al. Urinary Vitamin D Binding Protein and KIM-1 Are Potent New Biomarkers of Major Adverse Renal Events in Patients Undergoing Coronary Angiography , 2016, PloS one.
[3] K. Okasha,et al. Urinary level of vitamin D-binding protein as a new biomarker for diabetic nephropathy , 2016 .
[4] Yuan Wang,et al. Changes in serum and urine vitamin D binding protein concentrations in type 2 diabetes , 2015 .
[5] R. El-Sokkary,et al. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus , 2015, Molecular and Cellular Biochemistry.
[6] V. Tesar,et al. Vitamin D Binding Protein Is Not Involved in Vitamin D Deficiency in Patients with Chronic Kidney Disease , 2015, BioMed research international.
[7] Yuqian Li,et al. Association of the vitamin D binding protein polymorphisms with the risk of type 2 diabetes mellitus: a meta-analysis , 2014, BMJ Open.
[8] S. Bajaj,et al. Vitamin D levels and microvascular complications in type 2 diabetes , 2014, Indian journal of endocrinology and metabolism.
[9] J. Ge,et al. Elevated urinary level of vitamin D-binding protein as a novel biomarker for diabetic nephropathy , 2013, Experimental and therapeutic medicine.
[10] G. Navis,et al. Urinary Vitamin D Binding Protein: A Potential Novel Marker of Renal Interstitial Inflammation and Fibrosis , 2013, PloS one.
[11] Wan-long Tan,et al. Identification of urinary Gc-globulin as a novel biomarker for bladder cancer by two-dimensional fluorescent differential gel electrophoresis (2D-DIGE). , 2012, Journal of proteomics.
[12] R. Thadhani,et al. Vitamin D therapy in chronic kidney disease and end stage renal disease. , 2012, Clinical journal of the American Society of Nephrology : CJASN.
[13] Sihyun Cho,et al. Urinary vitamin D-binding protein is elevated in patients with endometriosis. , 2012, Human reproduction.
[14] R. Gans,et al. Antiproteinuric treatment reduces urinary loss of vitamin D-binding protein but does not affect vitamin D status in patients with chronic kidney disease , 2012, The Journal of Steroid Biochemistry and Molecular Biology.
[15] N. Abdella,et al. Does Vitamin D deficiency play a role in peripheral neuropathy in Type 2 diabetes? , 2012, Diabetic medicine : a journal of the British Diabetic Association.
[16] G. Cockrell,et al. Enhanced excretion of vitamin D binding protein in type 1 diabetes: a role in vitamin D deficiency? , 2011, The Journal of clinical endocrinology and metabolism.
[17] Andrea M. Wessell,et al. The Association of Vitamin D Deficiency and Insufficiency with Diabetic Nephropathy: Implications for Health Disparities , 2009, The Journal of the American Board of Family Medicine.
[18] G. Cockrell,et al. Microalbuminuria in Type 1 Diabetes Is Associated With Enhanced Excretion of the Endocytic Multiligand Receptors Megalin and Cubilin , 2009, Diabetes Care.
[19] N. Wareham,et al. Baseline Serum 25-Hydroxy Vitamin D Is Predictive of Future Glycemic Status and Insulin Resistance , 2008, Diabetes.
[20] Bess Dawson-Hughes,et al. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. , 2007, The Journal of clinical endocrinology and metabolism.
[21] J. Manson,et al. Vitamin D and calcium intake in relation to type 2 diabetes in women. , 2006, Diabetes care.
[22] E. Ford,et al. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. , 2005, Diabetes care.
[23] M. Saad,et al. Hypovitaminosis D is associated with insulin resistance and β cell dysfunction , 2004 .
[24] Daniel W. Jones,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.
[25] W. Herman,et al. Does microalbuminuria predict diabetic nephropathy? , 2001, Diabetes care.
[26] S. Adami,et al. High prevalence of hypovitaminosis D in female type 2 diabetic population. , 2001, Diabetes care.
[27] P. White,et al. The Multifunctional Properties and Characteristics of Vitamin D-binding Protein , 2000, Trends in Endocrinology & Metabolism.
[28] Henrik Vorum,et al. An Endocytic Pathway Essential for Renal Uptake and Activation of the Steroid 25-(OH) Vitamin D3 , 1999, Cell.
[29] R. Kahn. Proceedings of a consensus development conference on standardized measures in diabetic neuropathy. Autonomic nervous system testing. , 1992, Diabetes care.
[30] J. Haddad,et al. Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. , 1986, The Journal of clinical endocrinology and metabolism.
[31] D. Ewing,et al. Assessment of cardiovascular effects in diabetic autonomic neuropathy and prognostic implications. , 1980, Annals of internal medicine.
[32] R. Levy,et al. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.
[33] H. Taskapan,et al. 25(OH) Vitamin D3 in patients with chronic kidney disease and those on dialysis: rediscovering its importance , 2006, International Urology and Nephrology.
[34] Y. Jang,et al. Standards of Medical Care in Diabetes-2010 by the American Diabetes Association: Prevention and Management of Cardiovascular Disease , 2010 .